News
Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial ...
Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program advancing an epigenetic therapy with the potential to revolutionize the treatment landscape for ...
Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program ...
The Pirates, who won back-to-back titles in 2022 and 2021, are going back to the state championship series next week after ...
is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics, a pioneering epigenetic editing company.
Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine ...
Biotechnology company United Therapeutics (NASDAQ:UTHR) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 17.2% year on year to $794.4 million. Its GAAP profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results